Publications
Found 4 results
Filters: Author is D.L. Man [Clear All Filters]
“Expression and significance of miR-21 in multiple myeloma patients”, vol. 15, p. -, 2016.
, “Expression and significance of miR-21 in multiple myeloma patients”, vol. 15, p. -, 2016.
, “Expression and significance of miR-21 in multiple myeloma patients”, vol. 15, p. -, 2016.
, “Vascular endothelial growth factor gene polymorphisms and colorectal cancer risk: a meta-analysis”, vol. 10, pp. 3674-3688, 2011.
,
Bae SJ, Kim JW, Kang H, Hwang SG, et al. (2008). Gender-specific association between polymorphism of vascular endothelial growth factor (VEGF 936 C>T) gene and colon cancer in Korea. Anticancer Res. 28: 1271-1276.
PMid:18505065
Brogan IJ, Khan N, Isaac K, Hutchinson JA, et al. (1999). Novel polymorphisms in the promoter and 5' UTR regions of the human vascular endothelial growth factor gene. Hum. Immunol. 60: 1245-1249.
http://dx.doi.org/10.1016/S0198-8859(99)00132-9
Cacev T, Loncar B, Seiwerth S, Spavanti S, et al. (2008). Vascular endothelial growth factor polymorphisms -1154 G/A and -460 C/T are not associated with VEGF mRNA expression and susceptibility to sporadic colon cancer. DNA Cell Biol. 27: 569-574.
http://dx.doi.org/10.1089/dna.2008.0756
PMid:18613756
Cao C, Ying T, Fang JJ, Sun SF, et al. (2010). Polymorphism of vascular endothelial growth factor -2578C/A with cancer risk: evidence from 11263 subjects. Med. Oncol. [Ahead of print].
Carmeliet P and Jain RK (2000). Angiogenesis in cancer and other diseases. Nature 407: 249-257.
http://dx.doi.org/10.1038/35025220
PMid:11001068
Chae YS, Kim JG, Sohn SK, Cho YY, et al. (2008). Association of vascular endothelial growth factor gene polymorphisms with susceptibility and clinicopathologic characteristics of colorectal cancer. J. Korean Med. Sci. 23: 421-427.
http://dx.doi.org/10.3346/jkms.2008.23.3.421
PMid:18583877 PMCid:2526538
Clapper ML (2000). Genetic polymorphism and cancer risk. Curr. Oncol. Rep. 2: 251-256.
http://dx.doi.org/10.1007/s11912-000-0075-z
PMid:11122850
Dassoulas K, Gazouli M, Rizos S, Theodoropoulos G, et al. (2009). Common polymorphisms in the vascular endothelial growth factor gene and colorectal cancer development, prognosis, and survival. Mol. Carcinog. 48: 563-569.
http://dx.doi.org/10.1002/mc.20495
PMid:19009560
Des Guetz G, Uzzan B, Nicolas P, Cucherat M, et al. (2006). Microvessel density and VEGF expression are prognostic factors in colorectal cancer. Meta-analysis of the literature. Br. J. Cancer 94: 1823-1832.
http://dx.doi.org/10.1038/sj.bjc.6603176
PMid:16773076 PMCid:2361355
Duthie SJ (2011). Epigenetic modifications and human pathologies: cancer and CVD. Proc. Nutr. Soc. 70: 47-56.
http://dx.doi.org/10.1017/S0029665110003952
PMid:21067630
Ferrara N (1999). Molecular and biological properties of vascular endothelial growth factor. J. Mol. Med. 77: 527-543.
http://dx.doi.org/10.1007/s001099900019
PMid:10494799
Ferrara N (2000). Vascular endothelial growth factor and the regulation of angiogenesis. Recent. Prog. Horm. Res. 55: 15-35.
PMid:11036931
Folkman J and Shing Y (1992). Angiogenesis. J. Biol. Chem. 267: 10931-10934.
PMid:1375931
Gasparini G, Toi M, Gion M, Verderio P, et al. (1997). Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma. J. Natl. Cancer Inst. 89: 139-147.
http://dx.doi.org/10.1093/jnci/89.2.139
PMid:8998183
Hanahan D and Folkman J (1996). Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86: 353-364.
http://dx.doi.org/10.1016/S0092-8674(00)80108-7
Higgins JP and Thompson SG (2002). Quantifying heterogeneity in a meta-analysis. Stat. Med. 21: 1539-1558.
http://dx.doi.org/10.1002/sim.1186
PMid:12111919
Hofmann G, Langsenlehner U, Renner W, Langsenlehner T, et al. (2008). Common single nucleotide polymorphisms in the vascular endothelial growth factor gene and colorectal cancer risk. J. Cancer Res. Clin. Oncol. 134: 591-595.
http://dx.doi.org/10.1007/s00432-007-0322-x
PMid:17938959
Knight JC (2005). Regulatory polymorphisms underlying complex disease traits. J. Mol. Med. 83: 97-109.
http://dx.doi.org/10.1007/s00109-004-0603-7
PMid:15592805 PMCid:3132451
Kuramochi H, Hayashi K, Uchida K, Miyakura S, et al. (2006). Vascular endothelial growth factor messenger RNA expression level is preserved in liver metastases compared with corresponding primary colorectal cancer. Clin. Cancer Res. 12: 29-33.
http://dx.doi.org/10.1158/1078-0432.CCR-05-1275
PMid:16397020
Liu L, Liu L, Zeng F, Wang K, et al. (2010). Meta-analysis of the association between VEGF-634 G>C and risk of malignancy based on 23 case-control studies. J. Cancer Res. Clin. Oncol. 137: 1027-1036.
http://dx.doi.org/10.1007/s00432-010-0966-9
PMid:21174216
Maltese P, Canestrari E, Ruzzo A, Graziano F, et al. (2009). VEGF gene polymorphisms and susceptibility to colorectal cancer disease in Italian population. Int. J. Colorectal Dis. 24: 165-170.
http://dx.doi.org/10.1007/s00384-008-0586-x
PMid:18830612
Park HM, Hong SH, Kim JW, Oh D, et al. (2007). Gender-specific association of the VEGF -2578C > A polymorphism in Korean patients with colon cancer. Anticancer Res. 27: 2535-2539.
PMid:17695550
Peters JL, Sutton AJ, Jones DR, Abrams KR, et al. (2006). Comparison of two methods to detect publication bias in meta-analysis. JAMA 295: 676-680.
http://dx.doi.org/10.1001/jama.295.6.676
PMid:16467236
Ponder BA (2001). Cancer genetics. Nature 411: 336-341.
http://dx.doi.org/10.1038/35077207
PMid:11357140
Renner W, Kotschan S, Hoffmann C, Obermayer-Pietsch B, et al. (2000). A common 936 C/T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels. J. Vasc. Res. 37: 443-448.
http://dx.doi.org/10.1159/000054076
PMid:11146397
Rothwell PM, Wilson M, Elwin CE, Norrving B, et al. (2010). Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials. Lancet 376: 1741-1750.
http://dx.doi.org/10.1016/S0140-6736(10)61543-7
Saad RS, Kordunsky L, Liu YL, Denning KL, et al. (2006). Lymphatic microvessel density as prognostic marker in colorectal cancer. Mod. Pathol. 19: 1317-1323.
http://dx.doi.org/10.1038/modpathol.3800651
PMid:16799477
Schott RJ and Morrow LA (1993). Growth factors and angiogenesis. Cardiovasc. Res. 27: 1155-1161.
http://dx.doi.org/10.1093/cvr/27.7.1155
PMid:7504584
Taby R and Issa JP (2010). Cancer epigenetics. CA Cancer J. Clin. 60: 376-392.
http://dx.doi.org/10.3322/caac.20085
PMid:20959400
Takahashi Y, Kitadai Y, Bucana CD, Cleary RK, et al. (1995). Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res. 55: 3964-3968.
PMid:7664263
Tanigawa N, Amaya H, Matsumura M, Lu C, et al. (1997). Tumor angiogenesis and mode of metastasis in patients with colorectal cancer. Cancer Res. 57: 1043-1046.
PMid:9067267
van Engeland M, Derks S, Smits KM, Meijer GA, et al. (2011). Colorectal cancer epigenetics: complex simplicity. J. Clin. Oncol. 29: 1382-1391.
http://dx.doi.org/10.1200/JCO.2010.28.2319
PMid:21220596
Vandenbroucke JP, von EE, Altman DG, Gotzsche PC, et al. (2007). Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Epidemiology 18: 805-835.
http://dx.doi.org/10.1097/EDE.0b013e3181577511
PMid:18049195
Venkatachalam R, Ligtenberg MJ, Hoogerbrugge N, de Bruijn DR, et al. (2010). The epigenetics of (hereditary) colorectal cancer. Cancer Genet. Cytogenet. 203: 1-6.
http://dx.doi.org/10.1016/j.cancergencyto.2010.08.013
PMid:20951312
Viechtbauer W (2007). Confidence intervals for the amount of heterogeneity in meta-analysis. Stat. Med. 26: 37-52.
http://dx.doi.org/10.1002/sim.2514
PMid:16463355
Vincenti V, Cassano C, Rocchi M and Persico G (1996). Assignment of the vascular endothelial growth factor gene to human chromosome 6p21.3. Circulation 93: 1493-1495.
http://dx.doi.org/10.1161/01.CIR.93.8.1493
PMid:8608615
Watson CJ, Webb NJ, Bottomley MJ and Brenchley PE (2000). Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production. Cytokine 12: 1232-1235.
http://dx.doi.org/10.1006/cyto.2000.0692
PMid:10930302
Weitz J, Koch M, Debus J, Höhler T, et al. (2005). Colorectal cancer. Lancet 365: 153-165.
http://dx.doi.org/10.1016/S0140-6736(05)17706-X
Wu GY, Wang XM, Keese M, Hasenberg T, et al. (2006). Association between vascular endothelial growth factor gene 936 T/C polymorphism and colorectal cancer together with anastomotic leakage. Zhonghua Wai Ke Za Zhi 44: 1505-1507.
PMid:17349182
Zintzaras E and Ioannidis JP (2005). Heterogeneity testing in meta-analysis of genome searches. Genet. Epidemiol. 28: 123-137.
http://dx.doi.org/10.1002/gepi.20048
PMid:15593093